| P50 | author | Ulrich Sauerzopf | Q56796268 |
| | Matthäus Willeit | Q96071895 |
| | Nicole Praschak-Rieder | Q130271888 |
| | Harald H Sitte | Q39484473 |
| | Ana Popovic | Q42305723 |
| P2093 | author name string | Roberto Sacco | |
| | Gaia Novarino | |
| | Marco Niello | |
| P2860 | cites work | Infant motor development and adult cognitive functions in schizophrenia. | Q51987059 |
| | The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies | Q73553209 |
| | [Primary & secondary symptoms in schizophrenia] | Q74649011 |
| | Modeling brain disease in a dish: really? | Q48471179 |
| | Altered oxygen metabolism associated to neurogenesis of induced pluripotent stem cells derived from a schizophrenic patient | Q48860052 |
| | A systematic review of the prevalence of schizophrenia | Q21144720 |
| | Finding the missing heritability of complex diseases | Q22122198 |
| | Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis | Q22242068 |
| | Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication | Q22253034 |
| | Brain-Region-Specific Organoids Using Mini-bioreactors for Modeling ZIKV Exposure | Q24004552 |
| | Biological insights from 108 schizophrenia-associated genetic loci | Q24561833 |
| | MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation | Q24628741 |
| | Modelling schizophrenia using human induced pluripotent stem cells | Q24633007 |
| | Direct conversion of fibroblasts to functional neurons by defined factors | Q24641912 |
| | iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson's disease | Q27321433 |
| | Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 |
| | Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 |
| | Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics | Q28081249 |
| | Disruption of two novel genes by a translocation co-segregating with schizophrenia | Q28144559 |
| | Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies | Q28190066 |
| | Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress | Q28257571 |
| | Schizophrenia risk from complex variation of complement component 4 | Q28272545 |
| | FOXG1-Dependent Dysregulation of GABA/Glutamate Neuron Differentiation in Autism Spectrum Disorders | Q28973611 |
| | Cerebral organoids model human brain development and microcephaly | Q28973619 |
| | Epigenetic memory in induced pluripotent stem cells | Q29547892 |
| | The Ink4/Arf locus is a barrier for iPS cell reprogramming | Q29614210 |
| | Missing heritability and strategies for finding the underlying causes of complex disease | Q29614586 |
| | Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling | Q29615601 |
| | Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease | Q29615682 |
| | Direct generation of functional dopaminergic neurons from mouse and human fibroblasts | Q29616184 |
| | Animal models of schizophrenia. | Q30462828 |
| | Label-free, live optical imaging of reprogrammed bipolar disorder patient-derived cells reveals a functional correlate of lithium responsiveness. | Q30586696 |
| | Roles of heat shock factor 1 in neuronal response to fetal environmental risks and its relevance to brain disorders. | Q33733359 |
| | Immunocytochemical localization of the dopamine transporter in human brain | Q33864441 |
| | Pluripotent stem cells in neurodegenerative and neurodevelopmental diseases. | Q33871319 |
| | Impaired metabolic reactivity to oxidative stress in early psychosis patients | Q34048645 |
| | Concise review: the promise of human induced pluripotent stem cell-based studies of schizophrenia | Q34051160 |
| | Direct conversion of human fibroblasts to dopaminergic neurons | Q34190302 |
| | Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells | Q34236195 |
| | 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists | Q34242473 |
| | Family, twin, and adoption studies of bipolar disorder | Q34274776 |
| | Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia | Q34276729 |
| | Adult mental health disorders and their age at onset | Q34320812 |
| | In vivo amphetamine action is contingent on αCaMKII | Q34393113 |
| | Organogenesis in a dish: modeling development and disease using organoid technologies | Q34429586 |
| | Human iPSC neurons display activity-dependent neurotransmitter secretion: aberrant catecholamine levels in schizophrenia neurons | Q34469459 |
| | Modeling a genetic risk for schizophrenia in iPSCs and mice reveals neural stem cell deficits associated with adherens junctions and polarity | Q34540416 |
| | A Comparative View on Human Somatic Cell Sources for iPSC Generation | Q34560769 |
| | Persistent infection by HSV-1 is associated with changes in functional architecture of iPSC-derived neurons and brain activation patterns underlying working memory performance | Q34700999 |
| | The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs | Q34706538 |
| | Stem cells on the brain: modeling neurodevelopmental and neurodegenerative diseases using human induced pluripotent stem cells | Q34845881 |
| | Path from schizophrenia genomics to biology: gene regulation and perturbation in neurons derived from induced pluripotent stem cells and genome editing | Q35095120 |
| | Your brain under the microscope: the promise of stem cells | Q35204234 |
| | Dysregulation of miR-34a links neuronal development to genetic risk factors for bipolar disorder. | Q35553863 |
| | Characterization of bipolar disorder patient-specific induced pluripotent stem cells from a family reveals neurodevelopmental and mRNA expression abnormalities | Q35634683 |
| | MicroRNA Profiling of Neurons Generated Using Induced Pluripotent Stem Cells Derived from Patients with Schizophrenia and Schizoaffective Disorder, and 22q11.2 Del. | Q35691087 |
| | Genetic Variability Overrides the Impact of Parental Cell Type and Determines iPSC Differentiation Potential | Q35896332 |
| | Apoptotic markers in cultured fibroblasts correlate with brain metabolites and regional brain volume in antipsychotic-naive first-episode schizophrenia and healthy controls. | Q36043389 |
| | Aging and reprogramming: a two-way street | Q36518127 |
| | Differential responses to lithium in hyperexcitable neurons from patients with bipolar disorder | Q36546243 |
| | Enhanced conversion of induced neuronal cells (iN cells) from human fibroblasts: Utility in uncovering cellular deficits in mental illness-associated chromosomal abnormalities | Q36640515 |
| | Characterization of molecular and cellular phenotypes associated with a heterozygous CNTNAP2 deletion using patient-derived hiPSC neural cells. | Q36680149 |
| | The TLX-miR-219 cascade regulates neural stem cell proliferation in neurodevelopment and schizophrenia iPSC model | Q36690461 |
| | Dysregulation of miRNA-9 in a Subset of Schizophrenia Patient-Derived Neural Progenitor Cells | Q36869455 |
| | Glutamate and dopamine in schizophrenia: an update for the 21st century | Q36992322 |
| | Increased abundance of translation machinery in stem cell-derived neural progenitor cells from four schizophrenia patients. | Q37058606 |
| | The nature of dopamine dysfunction in schizophrenia and what this means for treatment | Q37062793 |
| | Schizophrenia, "just the facts" 4. Clinical features and conceptualization | Q37425853 |
| | Transcripts involved in calcium signaling and telencephalic neuronal fate are altered in induced pluripotent stem cells from bipolar disorder patients | Q37663637 |
| | Integration-free induced pluripotent stem cells derived from schizophrenia patients with a DISC1 mutation | Q37734466 |
| | GSK-3 and Wnt Signaling in Neurogenesis and Bipolar Disorder | Q37982704 |
| | "Epigenetic memory" phenomenon in induced pluripotent stem cells | Q38181118 |
| | Vectorology and factor delivery in induced pluripotent stem cell reprogramming. | Q38195650 |
| | Mitochondrial dysfunction in schizophrenia: pathways, mechanisms and implications | Q38275087 |
| | Modeling hippocampal neurogenesis using human pluripotent stem cells | Q38460557 |
| | A dangerous method? The use of induced pluripotent stem cells as a model for schizophrenia. | Q38551127 |
| | Neurodevelopmental origins of bipolar disorder: iPSC models | Q38647935 |
| | Valproate reverts zinc and potassium imbalance in schizophrenia-derived reprogrammed cells | Q39018724 |
| | Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited | Q40635954 |
| | Enhanced amphetamine-mediated dopamine release develops in PC12 cells after repeated amphetamine treatment | Q40704974 |
| | Synaptic dysregulation in a human iPS cell model of mental disorders | Q41534293 |
| | Combined negative effect of donor age and time in culture on the reprogramming efficiency into induced pluripotent stem cells. | Q41652946 |
| | Efficient derivation of functional floor plate tissue from human embryonic stem cells | Q41828883 |
| | Human iPSC-based modeling of late-onset disease via progerin-induced aging | Q41868474 |
| | Modeling schizophrenia using induced pluripotent stem cell-derived and fibroblast-induced neurons | Q42099548 |
| | Dopaminergic differentiation of schizophrenia hiPSCs | Q42331751 |
| | Schizophrenia and chromosomal deletions within 22q11.2. | Q42951453 |
| | Repeated, intermittent treatment with amphetamine induces neurite outgrowth in rat pheochromocytoma cells (PC12 cells). | Q44136673 |
| | Repeated amphetamine treatment induces neurite outgrowth and enhanced amphetamine-stimulated dopamine release in rat pheochromocytoma cells (PC12 cells) via a protein kinase C- and mitogen activated protein kinase-dependent mechanism. | Q44720722 |
| | Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients. | Q46970598 |
| | Development of patient-specific neurons in schizophrenia using induced pluripotent stem cells | Q47788549 |
| | Focal adhesion dynamics are altered in schizophrenia. | Q48130288 |
| | Features preceding diagnosis of bipolar versus major depressive disorders | Q48161109 |
| | Nanogrooved substrate promotes direct lineage reprogramming of fibroblasts to functional induced dopaminergic neurons | Q48338735 |
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bipolar disorder | Q131755 |
| | psychosis | Q170082 |
| | amine | Q167198 |
| | schizophrenia | Q41112 |
| | dopamine | Q170304 |
| | phenol | Q407142 |
| | genetic predisposition to disease | Q64843122 |
| | hydrocarbon | Q43648 |
| P304 | page(s) | 45-57 | |
| P577 | publication date | 2016-09-30 | |
| | 2017-01-01 | |
| P1433 | published in | European Journal of Neuroscience | Q5412733 |
| P1476 | title | Are reprogrammed cells a useful tool for studying dopamine dysfunction in psychotic disorders? A review of the current evidence | |
| P478 | volume | 45 | |